These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11136848)

  • 41. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.
    Nelson HD; O'Meara ES; Kerlikowske K; Balch S; Miglioretti D
    Ann Intern Med; 2016 Feb; 164(4):226-35. PubMed ID: 26756902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast cancer and clinical outcome among women over 60 years of age: a plead for more screening and alternative treatments.
    Sennerstam RB; Wiksell H; Schässburger KU; Auer GU
    Anal Quant Cytopathol Histpathol; 2012 Aug; 34(4):189-94. PubMed ID: 23016465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mammography: reviewing the evidence. Epidemiology aspect.
    Miller AB
    Can Fam Physician; 1993 Jan; 39():85-90. PubMed ID: 8435565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
    Joensuu H; Lehtimäki T; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Anttila A; Lundin M; Isola J; Lundin J
    JAMA; 2004 Sep; 292(9):1064-73. PubMed ID: 15339900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Re: Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
    Whittemore AS
    J Natl Cancer Inst; 2005 Mar; 97(5):400; author reply 400-1. PubMed ID: 15741577
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of treatment and mammography detection on breast cancer survival over time: 1990-2007.
    Kaplan HG; Malmgren JA; Atwood MK; Calip GS
    Cancer; 2015 Aug; 121(15):2553-61. PubMed ID: 25872471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Opinions, beliefs and awareness about the value of mammography screening].
    Steurer J
    Praxis (Bern 1994); 2010 Oct; 99(20):1177-8. PubMed ID: 20954423
    [No Abstract]   [Full Text] [Related]  

  • 49. Lower sensitivity of screening mammography after previous benign breast surgery.
    van Breest Smallenburg V; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; van Beek M; Louwman MW
    Int J Cancer; 2012 Jan; 130(1):122-8. PubMed ID: 21328339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
    Taplin SH; Ichikawa L; Yood MU; Manos MM; Geiger AM; Weinmann S; Gilbert J; Mouchawar J; Leyden WA; Altaras R; Beverly RK; Casso D; Westbrook EO; Bischoff K; Zapka JG; Barlow WE
    J Natl Cancer Inst; 2004 Oct; 96(20):1518-27. PubMed ID: 15494602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy.
    Barth RJ; Gibson GR; Carney PA; Mott LA; Becher RD; Poplack SP
    AJR Am J Roentgenol; 2005 Jan; 184(1):324-9. PubMed ID: 15615996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection by screening mammography is a powerful independent predictor of survival in women diagnosed with breast cancer.
    Johnson A; Shekhdar J
    Breast; 2005 Feb; 14(1):79. PubMed ID: 15695088
    [No Abstract]   [Full Text] [Related]  

  • 53. Breast cancer screening with mammography.
    Elwood JM; Cox B; Richardson AK
    Lancet; 1993 Jun; 341(8859):1531; author reply 1531-2. PubMed ID: 8099397
    [No Abstract]   [Full Text] [Related]  

  • 54. Screening mammography reduces morbidity of breast cancer treatment.
    Leung JW
    AJR Am J Roentgenol; 2005 May; 184(5):1508-9. PubMed ID: 15855106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Re: Efficacy of breast cancer screening in the community according to risk level.
    Duffy SW; Smith RA; Tabar L
    J Natl Cancer Inst; 2005 Nov; 97(22):1703; author reply 1703-4. PubMed ID: 16288125
    [No Abstract]   [Full Text] [Related]  

  • 56. Mammography screening: are women really giving informed consent?
    Baines CJ
    J Natl Cancer Inst; 2003 Oct; 95(20):1508-11. PubMed ID: 14559870
    [No Abstract]   [Full Text] [Related]  

  • 57. Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography.
    Tolmos J; Cutrone JA; Wang B; Vargas HI; Stuntz M; Mishkin FS; Diggles LE; Venegas RJ; Klein SR; Khalkhali I
    J Natl Cancer Inst; 1998 Jun; 90(11):846-9. PubMed ID: 9625173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50-79 in British Columbia.
    Coldman AJ; Phillips N; Olivotto IA; Gordon P; Warren L; Kan L
    J Med Screen; 2008; 15(4):182-7. PubMed ID: 19106258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Critical comment. "Breast cancer mortality in organized mammography screening in Denmark--a comparative Study"].
    Bucher HC
    Praxis (Bern 1994); 2010 Oct; 99(20):1219-20. PubMed ID: 20931498
    [No Abstract]   [Full Text] [Related]  

  • 60. Breast cancer screening with mammography.
    Hakama M
    Lancet; 1993 Jun; 341(8859):1531; author reply 1531-2. PubMed ID: 8099398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.